Join to View Full Profile
1475 NW 12th AveMiami, FL 33136
Phone+1 305-243-5302
Fax+1 954-210-1085
Dr. Ikpeazu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1998 - 2000
East Tennessee State University/Quillen College of MedicineFellowship, Hematology and Medical Oncology, 1996 - 1998
Meharry Medical CollegeResidency, Internal Medicine, 1994 - 1996
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1992 - 1994- Meharry Medical CollegeClass of 1992
Certifications & Licensure
FL State Medical License 2007 - 2026
TN State Medical License 1995 - 2013
MN State Medical License 1993 - 1995
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma Start of enrollment: 2013 Jun 03
Publications & Presentations
PubMed
- 18 citationsGenomic and Molecular Profiling of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Blockade Compared to Survival O...Hira Shaikh, Julie E McGrath, Brittany Hughes, Joanne Xiu, Pavel Brodskiy
Cancers. 2021-12-16 - 18 citationsThe Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer.Misako Nagasaka, Vijendra Singh, Yasmine Baca, Ammar Sukari, Chul Kim
Clinical Lung Cancer. 2021-10-18 - 83 citationsCharacterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer.Julia Judd, Nagla Abdel Karim, Hina Khan, Abdul Rafeh Naqash, Yasmine Baca
Molecular Cancer Therapeutics. 2021-09-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
